AzTrials
AzTrials

MiscarriageMisTherNCT05653414

Interest of a Short Early Psychological Care in Women With Miscarriage

A study testing short early psychological care associated with encouragement of early support consultation with generalist practitioner or midwife and encouragement of early support consultation with generalist practitioner or midwife in people with Miscarriage, run by Université de Reims Champagne-Ardenne.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Miscarriage is a very common complication of pregnancy, accounting for 15.3% (95% CI 12.5-18.7%) of diagnosed pregnancies. Miscarriage would affect one in ten women during her lifetime. Worldwide, 23 million miscarriages occur annually. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Miscarriage
What is being tested?
short early psychological care associated with encouragement of early support consultation with generalist practitioner or midwife and encouragement of early support consultation with generalist practitioner or midwife
Could I receive a placebo?
No, everyone receives an active treatment
How many people
932 participants
Where
No sites listed yet
Study dates
30 May 2023to 1 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • women with an early miscarriage (defined by a spontaneous termination of pregnancy before the 14th week of amenorrhea)
  • women aged more than 18
  • women agreeing to participate in the study (signing the informed consent form).

Who cannot join

  • ectopic pregnancy
  • molar pregnancy
  • women with recurrent miscarriages
  • women less than 18

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Interest of a Short Early Psychological Care in Women With Miscarriage: a Controlled Randomized Study

Miscarriage is a very common complication of pregnancy, accounting for 15.3% (95% CI 12.5-18.7%) of diagnosed pregnancies. Miscarriage would affect one in ten women during her lifetime. Worldwide, 23 million miscarriages occur annually.

Because of its frequency, miscarriage isoften considered as trivial event by caregivers. Still, miscarriage can be a traumatic event. Literature is consistent on the psychological morbidity associated with miscarriage. Anxiety, depression, post-traumatic stress have been studied in women after miscarriage. Cohort studies and clinical trials suggest that psychological and supportive interventions performed in women after miscarriage may improve women's psychological well-being and reduce miscarriage complications in subsequent pregnancies. However, to date, the literature is considered insufficient on the psychological care of women after a miscarriage.

Read the detailed description

The aim of the study will be to evaluate the interest of a short early psychological care in women with miscarriage.

Conditions
Miscarriage
Being tested
short early psychological care associated with encouragement of early support consultation with generalist practitioner or midwife, encouragement of early support consultation with generalist practitioner or midwife
Keywords
Miscarriage, Psychological care, Anxiety, Depression, Post traumatic stress disorder
Medical subject headings
Abortion, Spontaneous, Anxiety Disorders, Depression, Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • short early psychological care associated with encouragement of early support consultation with generalist practitioner or midwifeOther

    4 consultations with a psychologist over 2 months maximum

  • encouragement of early support consultation with generalist practitioner or midwifeOther

    encouragement of early support consultation with generalist practitioner or midwife

Study groups in NCT05653414
Study groupRoleWhat they receive
"short early psychological care" groupExperimentalWomen with short early psychological care associated with encouragement of early support consultation with generalist practitioner or midwife
Receives: Other: short early psychological care associated with encouragement of early support consultation with generalist practitioner or midwife
"control" groupActive comparatorWomen with encouragement of early support consultation with generalist practitioner or midwife
Receives: Other: encouragement of early support consultation with generalist practitioner or midwife

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. anxiety

    Anxiety will be evaluated using the Scale Trait Anxiety Inventory version Y (STAI-Y-A). The STAI Form Y-A consists of a set of twenty item sonly focus on the psychological and not the somatic aspects of anxiety. The STAI Form Y-A is a self-reported questionnaire. Each item is scored from 1 to 4 and a sum score of all items is computed. Higher score indicates greater anxiety. Presence of anxiety will be defined by a score greater than or equal to 46.

    Measured: Month 3

Secondary outcomes (3)
  1. depression

    depression will be evaluated using Beck Depression Inventory - Second Edition (BDI-II). The BDI-II is a self-reported index of depressive symptoms experienced in the past 2 weeks. The questionnaire includes 21 items of depression symptoms and attitude that the subjects must answer on a 4-point scale from 0 to 3 (0 = not at all bothered; 3 = severely bothered). The minimum score in this questionnaire is 0 and the maximum is 63. Total score indicates that depression is minimal (from 0 to 11 points), mild (from 12 to 19 points), moderate (from 20 to 35 points), or severe (from 36 to 63 points). Presence of depression will be defined by a score greater than or equal to 19.

    Measured: month 3

  2. anxiety

    Anxiety will be evaluated using the Scale Trait Anxiety Inventory version Y (STAI-Y-A). The STAI Form Y-A consists of a set of twenty item sonly focus on the psychological and not the somatic aspects of anxiety. The STAI Form Y-A is a self-reported questionnaire. Each item is scored from 1 to 4 and a sum score of all items is computed. Higher score indicates greater anxiety. Presence of anxiety will be defined by a score greater than or equal to 46.

    Measured: month 6

  3. depression

    depression will be evaluated using Beck Depression Inventory - Second Edition (BDI-II). The BDI-II is a self-reported index of depressive symptoms experienced in the past 2 weeks. The questionnaire includes 21 items of depression symptoms and attitude that the subjects must answer on a 4-point scale from 0 to 3 (0 = not at all bothered; 3 = severely bothered). The minimum score in this questionnaire is 0 and the maximum is 63. Total score indicates that depression is minimal (from 0 to 11 points), mild (from 12 to 19 points), moderate (from 20 to 35 points), or severe (from 36 to 63 points). Presence of depression will be defined by a score greater than or equal to 19.

    Measured: month 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2022
  2. Study start30 May 2023 (estimated)
  3. Primary completion1 Aug 2025 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
932 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05653414
Sponsor's protocol ID
2022_RIPH_003_MisTher
Acronym
MisTher
Status last verified
Dec 2022
First submitted
7 Dec 2022
Last updated
15 May 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Barbe C, Boiteux-Chabrier M, Charillon E, Bouazzi L, Maheas C, Merabet F, Graesslin O, Auer J, Hammami S, Rolland AC, Hurtaud A. Utility of early, short psychological care for women who experience early miscarriage: protocol for the randomized, controlled MisTher trial. BMC Psychol. 2023 Nov 3;11(1):368. doi: 10.1186/s40359-023-01421-x.

    PubMed 37924101

Questions about this trial

What is this clinical trial studying?

A study testing short early psychological care associated with encouragement of early support consultation with generalist practitioner or midwife and encouragement of early support consultation with generalist practitioner or midwife in people with Miscarriage, run by Université de Reims Champagne-Ardenne.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 15 May 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aline Hurtaud, Dr (0326918822 ext. +33, aline.ohl-hurtaud@univ-reims.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

anxiety (time frame: Month 3). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05653414, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in